Couldn't agree more. Saw the headline "Invivo Therapeutics sees FDA approval to start clinical study" on my phone along with a 28% increase in value this morning, and got all excited and was like "FINALLY". Then I actually read the letter to shareholders (a separate PR), and was a bit let down. I didn't really see anything new or different in there, that wasn't already known yesterday. Will be looking for confirmation that this rally has legs, and isn't just the result of a suspect headline and huge early move up before I add anything here.. I do appreciate they are communicating with the shareholders, but something definitely feels a bit off and since I don't know what's going on I'll protect my principle and wait (so maybe I only get a 100% return instead of a 300% return.. I'm ok with that so long as it means I'm not risking the potential of an 80% loss in principle... which has happened to me with early unlisted biotech before).